Revision as of 04:16, 3 July 2018 editZanhe (talk | contribs)Autopatrolled, Extended confirmed users, Pending changes reviewers132,020 edits expandTag: Visual edit← Previous edit | Latest revision as of 13:04, 4 November 2024 edit undoWabbuh (talk | contribs)Extended confirmed users2,978 editsNo edit summary | ||
(47 intermediate revisions by 29 users not shown) | |||
Line 1: | Line 1: | ||
{{Short description|Swedish neuroscientist (1923–2018)}} | |||
{{Use dmy dates|date= |
{{Use dmy dates|date=July 2018}} | ||
{{Infobox scientist | {{Infobox scientist | ||
|name = Arvid Carlsson | |name = Arvid Carlsson | ||
|image = |
|image = Arvid Carlsson 2011a (3x4 cropped).jpg | ||
|image_size = 250px | |||
|caption = Carlsson in 2011 | |caption = Carlsson in 2011 | ||
|birth_date = {{birth date|1923|1|25|df=y}} | |birth_date = {{birth date|1923|1|25|df=y}} | ||
Line 9: | Line 9: | ||
|death_date = {{death date and age|2018|6|29|1923|1|25|df=y}} | |death_date = {{death date and age|2018|6|29|1923|1|25|df=y}} | ||
|death_place = ], Sweden | |death_place = ], Sweden | ||
| |
|workplaces = ] | ||
|citizenship = | |||
|nationality = ] | |||
|ethnicity = | |||
|fields = | |||
|workplaces = | |||
|alma_mater = ] | |alma_mater = ] | ||
|doctoral_advisor = | |||
|academic_advisors = | |||
|doctoral_students = | |||
|notable_students = | |||
|known_for = ] | |known_for = ] | ||
⚫ | |awards = ] <small>(1979)</small><br>] <small>(1994)</small><ref name=jp>. Japan Prize</ref><br>] <small>(1999)</small><br>] <small>(2000)</small> | ||
|author_abbrev_bot = | |||
|author_abbrev_zoo = | |||
|influences = | |||
|influenced = | |||
⚫ | |awards = |
||
|religion = | |||
|signature = <!--(filename only)--> | |||
|footnotes = | |||
}} | }} | ||
⚫ | '''Arvid Carlsson''' (25 January 1923 – 29 June 2018)<ref name="untobit">{{cite news|url=http://unt.se/nyheter/omvarld/nobelpristagaren-arvid-carlsson-dod-5019874.aspx|title=Nobelpristagaren Arvid Carlsson död|date=30 June 2018|newspaper=]|access-date=30 June 2018|archive-url=https://web.archive.org/web/20180701030617/http://unt.se/nyheter/omvarld/nobelpristagaren-arvid-carlsson-dod-5019874.aspx|archive-date=1 July 2018|url-status=dead}}</ref><ref name="sahlgrenskaobit">{{cite web|url=https://sahlgrenska.gu.se/english/research/researchers/arvid-carlsson|title=In memory of Arvid Carlsson (1923-2018)|publisher=Sahlgrenska Academy|access-date=30 June 2018|archive-date=1 July 2018|archive-url=https://web.archive.org/web/20180701030548/https://sahlgrenska.gu.se/english/research/researchers/arvid-carlsson|url-status=dead}}</ref><ref name=":0">{{Cite news|url=https://mobile.nytimes.com/2018/07/01/obituaries/arvid-carlsson-who-discovered-a-treatment-for-parkinsons-dies-at-95.html|title=Arvid Carlsson, Who Discovered a Treatment for Parkinson's, Dies at 95|last=Gellene|first=Denise|date=1 July 2018|work=The New York Times|access-date=3 July 2018}}</ref> was a ] ] who is best known for his work with the ] ] and its effects in ]. For his work on dopamine, Carlsson was awarded the ] in 2000, together with ] and ].<ref name="Barondes">{{cite book| first=Samuel H.| last=Barondes| year=2003| title=Better Than Prozac| pages=| location=New York| publisher=Oxford University Press| isbn=978-0-19-515130-5| url=https://archive.org/details/betterthanprozac00baro/page/21}}</ref><ref>''Les Prix Nobel''. 2001. The Nobel Prizes 2000, Editor Tore Frängsmyr, Nobel Foundation: Stockholm.</ref> | ||
⚫ | '''Arvid Carlsson''' (25 January 1923 – 29 June 2018<ref name="untobit">{{cite news|url=http://unt.se/nyheter/omvarld/nobelpristagaren-arvid-carlsson-dod-5019874.aspx |
||
==Early life and education== | ==Early life and education== | ||
⚫ | Carlsson was born on 25 January 1923 in ], Sweden, one of four siblings. His family moved to ] after his father became a history professor at ]. Although his two older siblings followed their father's career path, he instead chose to study medicine at Lund, beginning in 1941.<ref name=":0" /><ref name=":1" /> | ||
⚫ | In 1944, he participated in the task of examining prisoners of Nazi concentration camps, whom Swedish ] ] had managed to bring to Sweden, which was neutral during ].<ref name=":0" /><ref name=":1" /> He received his MD and PhD in pharmacology in 1951.<ref name=":0" /> | ||
⚫ | Carlsson was born on 25 January 1923 in ], Sweden, one of four siblings. His family moved to Lund after his father became a history professor at |
||
⚫ | In 1944, he participated in the task of examining prisoners of Nazi concentration camps, whom Swedish ] ] had managed to bring to Sweden, which was neutral during ].<ref name=":0" /><ref name=":1" /> | ||
== Career == | == Career == | ||
In 1951, Carlsson became an associate professor at Lund University. He spent five months as a research fellow for the pharmacologist ] at the ] in ], United States, and the change in his research focus to ] eventually led to his Nobel Prize.<ref name=":0" /> In 1959 he became a professor at the ].<ref name=":0" /><ref name=":1" /> | |||
In 1957 ] |
In 1957 ] demonstrated the presence of dopamine in the human brain; later that same year Carlsson also demonstrated that dopamine was a neurotransmitter in the ] and not just a precursor for ].<ref name="pmid13483658">{{cite journal| first1=Arvid | last1=Carlsson| first2=Margit | last2=Lindqvist| first3=Tor | last3=Magnusson| title=3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists| journal=]| volume=180| issue=4596| pages=1200|date=November 1957| pmid=13483658| doi=10.1038/1801200a0| bibcode=1957Natur.180.1200C| s2cid=28141709| doi-access=free}}</ref><ref name="pmid17522649">{{cite journal |author=Abbott A |title=Neuroscience: the molecular wake-up call |journal=Nature |volume=447 |issue=7143 |pages=368–70 |year=2007 |pmid=17522649 |doi=10.1038/447368a|bibcode=2007Natur.447..368A |s2cid=4425376 }}</ref> Carlsson went on to develop a method for measuring the amount of dopamine in brain tissues. He found that dopamine levels in the ], a brain area important for movement, were particularly high. He then showed that giving animals the drug ] caused a decrease in dopamine levels and a loss of movement control. These effects were similar to the symptoms of Parkinson's disease. By administering to these animals ], which is the precursor of dopamine, he could alleviate the symptoms. These findings led other doctors to try using L-Dopa in patients with Parkinson's disease, and it was found to alleviate some of the symptoms in the early stages of the disease. L-Dopa is still the basis for most commonly used means of treating Parkinson's disease.<ref name="Barondes" /> | ||
Carlson collaborated with the drug company ] during the 1970s and the 1980s.<ref name="Squire1998">{{cite book|url=https://books.google.com/books?id=KwlzEFWw2J8C&pg=PA53|title=The History of Neuroscience in Autobiography| |
Carlson collaborated with the drug company ] (now ]) during the 1970s and the 1980s.<ref name="Squire1998">{{cite book|url=https://books.google.com/books?id=KwlzEFWw2J8C&pg=PA53|title=The History of Neuroscience in Autobiography|first=Larry R. | last=Squire|date=1998|publisher=Elsevier|isbn=978-0-08-053405-3|page=53}}</ref> He and his colleagues were able to ] the first marketed ] (SSRI), ], from ].<ref name="Barondes" /> Zimelidine was later withdrawn from the market due to rare cases of ],<ref>{{Cite web|url=http://www.dr-bob.org/babble/20060604/msgs/654587.html|title=History: Discovery of the SSRIs (long) {{!}} Psycho-Babble|website=www.dr-bob.org|access-date=22 June 2016}}</ref> but Carlson's research paved the way for ] (Prozac), one of the most widely used prescription medicines in the world.<ref name=":1" /> | ||
Carlsson was still an active researcher and speaker when he was over 90 years old |
Carlsson was still an active researcher and speaker when he was over 90 years old and, together with his daughter Lena, he worked<ref name=Gothenburg_uni>{{Cite web|url=http://www.gu.se/english/research/publication/?publicationId=165289|title=Publications card|date=25 November 2010|website=University of Gothenburg|access-date=22 June 2016|archive-date=8 August 2016|archive-url=https://web.archive.org/web/20160808101106/http://www.gu.se/english/research/publication/?publicationId=165289|url-status=dead}}</ref> on ], a dopamine stabilizer which alleviates symptoms of post-stroke fatigue.<ref>{{Cite web|url=http://www.brainmessenger.se/index_eng.htm|title=Arvid Carlsson and Lena Carlsson|website=www.BrainMessenger.se|access-date=22 June 2016}}</ref> | ||
== Honours and awards == | == Honours and awards == | ||
Carlsson's research on the brain's chemical signals and the resulting treatment for Parkinson's disease earned him the 2000 ], which he shared with ] and ].<ref name=":0" /><ref name=":1" /> He |
Carlsson's research on the brain's chemical signals and the resulting treatment for Parkinson's disease earned him the 2000 ], which he shared with ] and ].<ref name=":0" /><ref name=":1" /> He won many other awards including Israel's ] (1979), the ] (1994),<ref name=":1" /> and Italy's ] (1999).<ref>{{Cite web|url=http://www.lincei.it/premi/assegnati_feltrinelli.php|title=Accademia Nazionale dei Lincei - Premi e borse di studio - Premi "Antonio Feltrinelli" finora conferiti|website=Accademia dei Lincei|language=it|archive-url=https://web.archive.org/web/20140728111117/http://www.lincei.it/premi/assegnati_feltrinelli.php|archive-date=28 July 2014|access-date=3 July 2018|url-status=dead}}</ref> He was elected as a member of the ] in 1975.<ref name=":0" /> He was awarded an honorary Doctor of Science from the ] in 2007.<ref>{{Cite web |title=Past Recipients – Honorary Degrees |url=https://honorarydegrees.usc.edu/past-recipients/ |access-date=2024-05-08 |website=honorarydegrees.usc.edu}}</ref> | ||
== Personal life == | == Personal life == | ||
Carlsson married Ulla-Lisa Christoffersson in 1945 and they had three sons and two daughters. His daughter Maria was his lab manager |
Carlsson married Ulla-Lisa Christoffersson in 1945 and they had three sons and two daughters. His daughter Maria was his lab manager<ref name=":0" /><ref name=":1" /> and his daughter Lena was one of his collaborators.<ref name=Gothenburg_uni /> | ||
He opposed the ] of drinking water in Sweden.<ref></ref><ref>{{cite journal |vauthors=Torell P, Forsman B |title= |language=sv |journal=Tandlakartidningen |volume=71 |issue=3 |pages=142–57 |date=February 1979 |pmid=287207 }}</ref><ref>Bryson C. (2004) ''The Fluoride Deception''. Seven Stories Press. p. . {{ISBN|1583225269}}.</ref> He was a vocal opponent of ] and worked to prevent homeopathic preparations from being classified as medication in Sweden.<ref name="untobit" /> | |||
⚫ | Carlsson died on 29 June 2018, at the age of 95.<ref name=":0" /><ref name=":1">{{Cite |
||
⚫ | Carlsson died on 29 June 2018, at the age of 95.<ref name=":0" /><ref name=":1">{{Cite news|url=https://www.washingtonpost.com/local/obituaries/arvid-carlsson-nobel-laureate-who-uncovered-a-treatment-for-parkinsons-dies-at-95/2018/07/02/c13d9aee-7e00-11e8-b660-4d0f9f0351f1_story.html|title=Arvid Carlsson, Nobel laureate who uncovered a treatment for Parkinson's, dies at 95|last=Smith|first=Harrison|date=2 July 2018|newspaper=Washington Post|access-date=3 July 2018}}</ref> | ||
==Drugs== | |||
#] | |||
#] | |||
#] | |||
#] | |||
#] | |||
#] | |||
#] | |||
#] | |||
#] | |||
#] | |||
==References== | ==References== | ||
{{Reflist}} | {{Reflist}} | ||
Line 63: | Line 55: | ||
==External links== | ==External links== | ||
{{Commons category|Arvid Carlsson}} | {{Commons category|Arvid Carlsson}} | ||
*{{Nobelprize}} including the Nobel Lecture 8 December 2000 ''A Half-Century of Neurotransmitter Research: Impact on Neurology and Psychiatry'' | |||
* | |||
* | * | ||
{{Nobel Prize in Physiology or Medicine Laureates 1976-2000}} | {{Nobel Prize in Physiology or Medicine Laureates 1976-2000}} | ||
{{Swedish Nobel Laureates}} | {{Swedish Nobel Laureates}} | ||
{{Wolf Prize in Medicine}} | {{Wolf Prize in Medicine}} | ||
{{2000 Nobel Prize winners}} | |||
{{Japan Prize}} | |||
{{Authority control}} | {{Authority control}} | ||
{{DEFAULTSORT:Carlsson, Arvid}} | {{DEFAULTSORT:Carlsson, Arvid}} | ||
] | |||
] | |||
] | ] | ||
] | ] | ||
Line 78: | Line 73: | ||
] | ] | ||
] | ] | ||
] | ] | ||
] | ] | ||
] | ] | ||
] | ] | ||
] | ] | ||
] | |||
] |
Latest revision as of 13:04, 4 November 2024
Swedish neuroscientist (1923–2018)
Arvid Carlsson | |
---|---|
Carlsson in 2011 | |
Born | (1923-01-25)25 January 1923 Uppsala, Sweden |
Died | 29 June 2018(2018-06-29) (aged 95) Göteborg, Sweden |
Alma mater | Lund University |
Known for | Dopamine |
Awards | Wolf Prize in Medicine (1979) Japan Prize (1994) Feltrinelli International Award (1999) Nobel Prize in Physiology or Medicine (2000) |
Scientific career | |
Institutions | University of Gothenburg |
Arvid Carlsson (25 January 1923 – 29 June 2018) was a Swedish neuropharmacologist who is best known for his work with the neurotransmitter dopamine and its effects in Parkinson's disease. For his work on dopamine, Carlsson was awarded the Nobel Prize in Physiology or Medicine in 2000, together with Eric Kandel and Paul Greengard.
Early life and education
Carlsson was born on 25 January 1923 in Uppsala, Sweden, one of four siblings. His family moved to Lund after his father became a history professor at Lund University. Although his two older siblings followed their father's career path, he instead chose to study medicine at Lund, beginning in 1941.
In 1944, he participated in the task of examining prisoners of Nazi concentration camps, whom Swedish aristocrat Folke Bernadotte had managed to bring to Sweden, which was neutral during World War II. He received his MD and PhD in pharmacology in 1951.
Career
In 1951, Carlsson became an associate professor at Lund University. He spent five months as a research fellow for the pharmacologist Bernard Beryl Brodie at the National Heart Institute in Bethesda, Maryland, United States, and the change in his research focus to psychopharmacology eventually led to his Nobel Prize. In 1959 he became a professor at the University of Gothenburg.
In 1957 Katharine Montagu demonstrated the presence of dopamine in the human brain; later that same year Carlsson also demonstrated that dopamine was a neurotransmitter in the brain and not just a precursor for norepinephrine. Carlsson went on to develop a method for measuring the amount of dopamine in brain tissues. He found that dopamine levels in the basal ganglia, a brain area important for movement, were particularly high. He then showed that giving animals the drug reserpine caused a decrease in dopamine levels and a loss of movement control. These effects were similar to the symptoms of Parkinson's disease. By administering to these animals L-Dopa, which is the precursor of dopamine, he could alleviate the symptoms. These findings led other doctors to try using L-Dopa in patients with Parkinson's disease, and it was found to alleviate some of the symptoms in the early stages of the disease. L-Dopa is still the basis for most commonly used means of treating Parkinson's disease.
Carlson collaborated with the drug company Astra AB (now AstraZeneca) during the 1970s and the 1980s. He and his colleagues were able to derive the first marketed selective serotonin reuptake inhibitor (SSRI), zimelidine, from brompheniramine. Zimelidine was later withdrawn from the market due to rare cases of Guillain–Barré syndrome, but Carlson's research paved the way for fluoxetine (Prozac), one of the most widely used prescription medicines in the world.
Carlsson was still an active researcher and speaker when he was over 90 years old and, together with his daughter Lena, he worked on OSU6162, a dopamine stabilizer which alleviates symptoms of post-stroke fatigue.
Honours and awards
Carlsson's research on the brain's chemical signals and the resulting treatment for Parkinson's disease earned him the 2000 Nobel Prize in Physiology or Medicine, which he shared with Paul Greengard and Eric R. Kandel. He won many other awards including Israel's Wolf Prize in Medicine (1979), the Japan Prize (1994), and Italy's Feltrinelli Prize (1999). He was elected as a member of the Royal Swedish Academy of Sciences in 1975. He was awarded an honorary Doctor of Science from the University of Southern California in 2007.
Personal life
Carlsson married Ulla-Lisa Christoffersson in 1945 and they had three sons and two daughters. His daughter Maria was his lab manager and his daughter Lena was one of his collaborators.
He opposed the fluoridation of drinking water in Sweden. He was a vocal opponent of homeopathy and worked to prevent homeopathic preparations from being classified as medication in Sweden.
Carlsson died on 29 June 2018, at the age of 95.
Drugs
References
- Laureates of the Japan Prize. Japan Prize
- ^ "Nobelpristagaren Arvid Carlsson död". Upsala Nya Tidning. 30 June 2018. Archived from the original on 1 July 2018. Retrieved 30 June 2018.
- "In memory of Arvid Carlsson (1923-2018)". Sahlgrenska Academy. Archived from the original on 1 July 2018. Retrieved 30 June 2018.
- ^ Gellene, Denise (1 July 2018). "Arvid Carlsson, Who Discovered a Treatment for Parkinson's, Dies at 95". The New York Times. Retrieved 3 July 2018.
- ^ Barondes, Samuel H. (2003). Better Than Prozac. New York: Oxford University Press. pp. 21–22, 39–40. ISBN 978-0-19-515130-5.
- Les Prix Nobel. 2001. The Nobel Prizes 2000, Editor Tore Frängsmyr, Nobel Foundation: Stockholm.
- ^ Smith, Harrison (2 July 2018). "Arvid Carlsson, Nobel laureate who uncovered a treatment for Parkinson's, dies at 95". Washington Post. Retrieved 3 July 2018.
- Carlsson, Arvid; Lindqvist, Margit; Magnusson, Tor (November 1957). "3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists". Nature. 180 (4596): 1200. Bibcode:1957Natur.180.1200C. doi:10.1038/1801200a0. PMID 13483658. S2CID 28141709.
- Abbott A (2007). "Neuroscience: the molecular wake-up call". Nature. 447 (7143): 368–70. Bibcode:2007Natur.447..368A. doi:10.1038/447368a. PMID 17522649. S2CID 4425376.
- Squire, Larry R. (1998). The History of Neuroscience in Autobiography. Elsevier. p. 53. ISBN 978-0-08-053405-3.
- "History: Discovery of the SSRIs (long) | Psycho-Babble". www.dr-bob.org. Retrieved 22 June 2016.
- ^ "Publications card". University of Gothenburg. 25 November 2010. Archived from the original on 8 August 2016. Retrieved 22 June 2016.
- "Arvid Carlsson and Lena Carlsson". www.BrainMessenger.se. Retrieved 22 June 2016.
- "Accademia Nazionale dei Lincei - Premi e borse di studio - Premi "Antonio Feltrinelli" finora conferiti". Accademia dei Lincei (in Italian). Archived from the original on 28 July 2014. Retrieved 3 July 2018.
- "Past Recipients – Honorary Degrees". honorarydegrees.usc.edu. Retrieved 8 May 2024.
- Fluoride in drinking water can cause cancer, Svenska Dagbladet (in Swedish)
- Torell P, Forsman B (February 1979). "". Tandlakartidningen (in Swedish). 71 (3): 142–57. PMID 287207.
- Bryson C. (2004) The Fluoride Deception. Seven Stories Press. p. p. 240. ISBN 1583225269.
External links
- Arvid Carlsson on Nobelprize.org including the Nobel Lecture 8 December 2000 A Half-Century of Neurotransmitter Research: Impact on Neurology and Psychiatry
- The Sahlgrenska Academy at the University of Gothenburg
Lua error in Module:Navbox at line 535: attempt to get length of local 'arg' (a number value). Lua error in Module:Navbox at line 535: attempt to get length of local 'arg' (a number value). Lua error in Module:Navbox at line 535: attempt to get length of local 'arg' (a number value). Lua error in Module:Navbox at line 535: attempt to get length of local 'arg' (a number value). Lua error in Module:Navbox at line 535: attempt to get length of local 'arg' (a number value).
Categories:- 1923 births
- 2018 deaths
- Swedish neuroscientists
- Swedish pharmacologists
- Nobel laureates in Physiology or Medicine
- People connected to Lund University
- Wolf Prize in Medicine laureates
- Swedish Nobel laureates
- Academic staff of the University of Gothenburg
- Members of the Royal Swedish Academy of Sciences
- People from Uppsala
- 20th-century Swedish scientists
- 21st-century Swedish scientists
- Members of the National Academy of Medicine
- University of Gothenburg alumni